Business Description
Cardiff Oncology Inc
NAICS : 325414
SIC : 2836
ISIN : US8972384080
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 33.64 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.05 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.54 | |||||
Beneish M-Score | -3.36 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -15.1 | |||||
3-Year EBITDA Growth Rate | -3.8 | |||||
3-Year EPS without NRI Growth Rate | 4.5 | |||||
3-Year FCF Growth Rate | 3.9 | |||||
3-Year Book Growth Rate | -23.5 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.84 | |||||
9-Day RSI | 32.17 | |||||
14-Day RSI | 35.94 | |||||
6-1 Month Momentum % | 489 | |||||
12-1 Month Momentum % | 244.44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.91 | |||||
Quick Ratio | 5.91 | |||||
Cash Ratio | 5.67 | |||||
Days Sales Outstanding | 205.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.7 | |||||
Shareholder Yield % | 0.37 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -7261.15 | |||||
Net Margin % | -6594.92 | |||||
FCF Margin % | -5020 | |||||
ROE % | -51.37 | |||||
ROA % | -44.89 | |||||
ROIC % | -626.3 | |||||
ROC (Joel Greenblatt) % | -1415.29 | |||||
ROCE % | -55.43 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 265.47 | |||||
PB Ratio | 2.49 | |||||
Price-to-Tangible-Book | 2.49 | |||||
EV-to-EBIT | -1.94 | |||||
EV-to-EBITDA | -1.96 | |||||
EV-to-Revenue | 140.95 | |||||
EV-to-Forward-Revenue | 106.81 | |||||
EV-to-FCF | -2.81 | |||||
Price-to-Median-PS-Value | 1.36 | |||||
Price-to-Net-Current-Asset-Value | 2.67 | |||||
Price-to-Net-Cash | 2.8 | |||||
Earnings Yield (Greenblatt) % | -51.55 | |||||
FCF Yield % | -20.2 |